Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Neuroscience Letters

• Publication date

  1992-09-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0304-3940(92)90749-WPMID 1436703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of 3-hydroxykynurenine in human brain and plasma by high-performance liquid chromatography with electrochemical detection. Increased concentrations in hepatic encephalopathy.

  1991cited by this paper
• Kynurenine Pathway Measurements in Huntington's Disease Striatum: Evidence for Reduced Formation of Kynurenic Acid

  1990cited by this paper
• Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex.

  1989cited by this paper
• Increased brain 3-hydroxykynurenine in Huntington's disease.

  1989cited by this paper
• Increase in Kynurenic Acid in Huntington's Disease Motor Cortex

  1989cited by this paper
• Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line.

  1989cited by this paper
• Brain Quinolinic Acid in Huntington's Disease

  1988cited by this paper
• Increased Concentrations of 3‐Hydroxykynurenine in Vitamin B6 Deficient Neonatal Rat Brain

  1987cited by this paper
• Quinolinic acid and other kynurenines in the central nervous system.

  1985cited by this paper
• Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain.

  1983cited by this paper
• Effects of maternal vitamin B-6 deficiency on specific regions of developing rat brain: the extrapyramidal motor system.

  1983cited by this paper
• Kynurenines and Seizures

  1981cited by this paper
• An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post-mortem brain tissue.

  1979cited by this paper

• Dysregulation of the kynurenine pathway is related to persistent cognitive impairment in tick-borne encephalitis.

  2025cites this paper
• Gestational administration of Bifidobacterium dentium results in intergenerational modulation of inflammatory, metabolic, and social behavior.

  2024cites this paper
• 3-hydroxykynurenine is a ROS-inducing cytotoxic tryptophan metabolite that disrupts the TCA cycle

  2023cites this paper
• The Role of the Kynurenine/AhR Pathway in Diseases Related to Metabolism and Cancer

  2023cites this paper
• The Involvement of Kynurenine Pathway in Neurodegenerative Diseases

  2022cites this paper
• The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors

  2022cites this paper
• Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan–Kynurenine Metabolic System

  2022cites this paper
• Dynamic changes in metabolites of the kynurenine pathway in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: A systematic Review and meta-analysis

  2022influential citation
• Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders

  2021cites this paper
• Tryptophan Metabolism and Gut-Brain Homeostasis

  2021cites this paper
• A model of dopamine and serotonin-kynurenine metabolism in cortisolemia: Implications for depression

  2021cites this paper
• The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives

  2021cites this paper
• Electrochemical Determination of Kynurenine Pathway Metabolites—Challenges and Perspectives

  2021influential citation
• An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

  2020cites this paper
• Impaired metabolism of kynurenine and its metabolites in CSF of Parkinson's disease.

  2020cites this paper
• Simultaneous determination of 30 neurologically and metabolically important molecules: A sensitive and selective way to measure tyrosine and tryptophan pathway metabolites and other biomarkers in human serum and cerebrospinal fluid.

  2020cites this paper
• Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway

  2020cites this paper
• Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases.

  2020cites this paper
• Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice

  2020cites this paper
• Neuropathology of Kynurenine Pathway of Tryptophan Metabolism

  2020cites this paper
• Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development

  2019cites this paper
• Overexpression of Kynurenine 3-Monooxygenase Correlates with Cancer Malignancy and Predicts Poor Prognosis in Canine Mammary Gland Tumors

  2019cites this paper
• Title : An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

  2019cites this paper
• Fluid and imaging biomarkers for Huntington's disease.

  2019cites this paper
• Biofluid Biomarkers in Huntington's Disease.

  2018cites this paper
• Therapeutic approaches to Huntington disease: from the bench to the clinic

  2018cites this paper
• Assessing and Modulating Kynurenine Pathway Dynamics in Huntington's Disease: Focus on Kynurenine 3-Monooxygenase.

  2018cites this paper
• Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington’s disease

  2018cites this paper
• Linking the biological underpinnings of depression: Role of mitochondria interactions with melatonin, inflammation, sirtuins, tryptophan catabolites, DNA repair and oxidative and nitrosative stress, with consequences for classification and cognition.

  2018cites this paper
• A Three-Ring Circus: Metabolism of the Three Proteogenic Aromatic Amino Acids and Their Role in the Health of Plants and Animals

  2018cites this paper
• Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.

  2018cites this paper
• Investigating the Role of the Gut Microbiome in Huntington Disease

  2018cites this paper
• Body image dissatisfaction in pregnant and non-pregnant females is strongly predicted by immune activation and mucosa-derived activation of the tryptophan catabolite (TRYCAT) pathway

  2018cites this paper
• Kynurenic acid accumulation underlies learning and memory impairment associated with aging

  2018cites this paper
• Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model

  2018cites this paper
• Huntington’s Disease

  2018cites this paper
• Studying Huntington’s Disease in Yeast: From Mechanisms to Pharmacological Approaches

  2018cites this paper
• 3-Hydroxykynurenine and 3-Hydroxyanthranilic Acid Enhance the Toxicity Induced by Copper in Rat Astrocyte Culture

  2017cites this paper
• Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases

  2017cites this paper
• EFFECTS OF THE NOVEL IDO INHIBITOR DWG-1036 ON THE BEHAVIOUR AND NEUROCHEMISTRY OF THE TRIPLE TRANSGENIC MOUSE MODEL OF ALZHEIMER’S DISEASE

  2017cites this paper
• Crystal structures of human 3-hydroxyanthranilate 3,4-dioxygenase with native and non-native metals bound in the active site.

  2017cites this paper
• The beneficial effects of dietary restriction on learning are distinct from its effects on longevity and mediated by depletion of a neuroinhibitory metabolite

  2017cites this paper
• Characterisation of the active site of kynurenine 3-monooxygenase

  2016cites this paper
• Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism.

  2016cites this paper
• Effects of Various Kynurenine Metabolites on Respiratory Parameters of Rat Brain, Liver and Heart Mitochondria

  2016cites this paper
• Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression.

  2016cites this paper
• TDO as a therapeutic target in brain diseases

  2016cites this paper
• The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease.

  2016cites this paper
• Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors.

  2016cites this paper
• Functional and Localization Studies of Human Kynurenine 3-Monooxygenase

  2016cites this paper
• Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology

  2015influential citation
• Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations

  2015cites this paper
• A systems-level “misunderstanding”: the plasma metabolome in Huntington’s disease

  2015cites this paper
• Novel kynurenic acid analogues in the treatment of migraine and neurodegenerative disorders: preclinical studies and pharmaceutical design.

  2015cites this paper
• Central nervous system-specific alterations in the tryptophan metabolism in the 3-nitropropionic acid model of Huntington's disease.

  2015cites this paper
• The potential role of kynureninesin Alzheimer ' s disease-pathomechanism and therapeuticpossibilitiesbyinfluencing the glutamate receptors

  2015cites this paper
• The Kynurenine Pathway at the Interface Between Neuroinflammation, Oxidative Stress, and Neurochemical Disturbances: Emphasis in Schizophrenia

  2015cites this paper
• The Role of the Kynurenine Pathway in Neurodegenerative Diseases

  2015cites this paper
• Endogenous Kynurenic Acid and Neurotoxicity

  2014cites this paper
• The potential role of kynurenines in Alzheimer’s disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors

  2014cites this paper
• Quinolinate and related excitotoxins: mechanisms of neurotoxicity and disease relevance

  2014cites this paper
• Kynurenines in CNS disease: regulation by inflammatory cytokines

  2014cites this paper
• The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors

  2014cites this paper
• Dysregulation of the kynurenine pathway in psychotic disorders : immunological aspects

  2014cites this paper
• Neuroprotection by kynurenine metabolites

  2014cites this paper
• Tryptophan metabolism: entering the field of aging and age-related pathologies.

  2013cites this paper
• 3-Hydroxykynurenine: an intriguing molecule exerting dual actions in the central nervous system.

  2013cites this paper
• The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders

  2013cites this paper
• The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease

  2013cites this paper
• Structure and mechanism of kynurenine 3-monooxygenase, a candidate huntington’s disease drug target

  2013cites this paper
• Structural dynamics and ligand binding in kynurenine-3- monooxygenase

  2013cites this paper
• Kynurenines in the CNS: recent advances and new questions

  2012cites this paper
• Kynurenines in the mammalian brain: when physiology meets pathology

  2012cites this paper
• Protein oxidation in Huntington disease

  2012cites this paper
• Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.

  2012cites this paper
• Involvement of kynurenines in Huntington’s disease and stroke-induced brain damage

  2012cites this paper
• Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines

  2011cites this paper
• Creatine and pyruvate prevent behavioral and oxidative stress alterations caused by hypertryptophanemia in rats

  2011cites this paper
• Blood levels of kynurenines, interleukin‐23 and soluble human leucocyte antigen‐G at different stages of Huntington’s disease

  2010cites this paper
• EFECTO DE LOS PRETRATAMIENTOS SOLOS Y COMBINADO DE PROBENECID Y KINURENINA SOBRE EL DAÑO OXIDATIVO EN UN MODELO EXPERIMENTAL DE LA

  2010cites this paper
• Neuropathology of Post-stroke Depression: Possible Role of Inflammatory Molecules and Indoleamine 2,3-dioxygenase

  2010cites this paper
• Kynurenine and its metabolites in Alzheimer's disease patients.

  2010cites this paper
• Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington's disease.

  2010cites this paper
• Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

  2010cites this paper
• Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington’s disease

  2010cites this paper
• Kynurenine inhibits fibroblast growth factor 2-mediated expression of crystallins and MIP26 in lens epithelial cells.

  2010cites this paper
• Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies

  2009cites this paper
• Kynurenine Pathway Metabolites in Humans: Disease and Healthy States

  2009cites this paper
• The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.

  2009cites this paper
• Magnolol Attenuates Neuronal Cell Death Induced by Kynurenine Metabolite

  2009cites this paper
• UV-B irradiation-induced electron transfer between 3-hydroxykynurenine and tryptophan

  2009cites this paper
• Proinflammatory cytokine interferon‐γ increases induction of indoleamine 2,3‐dioxygenase in monocytic cells primed with amyloid β peptide 1–42: implications for the pathogenesis of Alzheimer’s disease

  2009cites this paper
• Erratum to: Milk Containing BF-7 Enhances the Learning and Memory, Attention, and Mathematical Ability of Normal Persons

  2009cites this paper
• Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons.

  2008cites this paper
• Histone Deacetylase Inhibition Modulates Kynurenine Pathway Activation in Yeast, Microglia, and Mice Expressing a Mutant Huntingtin Fragment*

  2008cites this paper
• Simultaneous measurement of tryptophan and related compounds by liquid chromatography/electrospray ionization tandem mass spectrometry.

  2008cites this paper
• Kynurenines in neurological disorders

  2007cites this paper
• In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain.

  2007cites this paper
• Tryptophan, adenosine, neurodegeneration and neuroprotection

  2007cites this paper
• Integrative hypothesis for Huntington's disease: a brief review of experimental evidence.

  2007cites this paper